PARIS, June 12, 2025 /CNW/ - diaMentis, a company developing an innovative diagnostic support technology in mental health, recognized by the U.S. Food and Drug Administration (FDA) as a scientific breakthrough, has recently been selected by Dassault Systèmes to join its prestigious 3DEXPERIENCE Lab accelerator program. This unique program provides a hand-picked group of startups access to cutting-edge technological tools and resources to support the development of breakthrough solutions to today's global challenges.
Read more at newswire.cadiaMentis selected by Dassault Systèmes to join an exclusive group of innovative companies in the 3DEXPERIENCE Lab accelerator program
Newswire.ca -
Thu Jun 12, 2:00PM CDT
Columnist
Contributor Content
Press Release
Sponsored Content
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.